Understand the source comparison
Melatonin Mechanism of Action Detailed: Comparison of Receptor Subtypes and Clinical Applications
MT1 (MEL1A) Suprachiasmatic nucleus (ventrolateral), retina, hippocampus Gi/Go-coupled receptor; inhibits adenylyl cyclase, reduces cAMP, hyperpolarizes neurons Acute suppression of SCN neuronal firing; signals biological nighttime Immediate sleep-promoting ef
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- MT1 (MEL1A)
- Suprachiasmatic nucleus (ventrolateral), retina, hippocampus
- Gi/Go-coupled receptor; inhibits adenylyl cyclase, reduces cAMP, hyperpolarizes neurons
- Acute suppression of SCN neuronal firing; signals biological nighttime
- Immediate sleep-promoting effects; used for sleep-onset insomnia when timed 60–90 min before bed
- MT1 is the primary target for acute sleep latency reduction. But efficacy plateaus above 0.5mg due to receptor saturation
- MT2 (MEL1B)
- Suprachiasmatic nucleus (dorsomedial), retina, blood vessels
- Gi/Go-coupled receptor; modulates SCN oscillatory amplitude and phase
- Phase-shifts circadian rhythms (advance or delay depending on timing)
- Jet lag, shift work disorder, delayed/advanced sleep phase syndrome
- MT2 activation requires precise timing relative to DLMO. Mistimed dosing can worsen circadian misalignment rather than correct it
- MT3 (Non-Receptor)
- Liver, kidney, brain (diffuse)
- Quinone reductase enzyme (not a true GPCR); reduces quinones to prevent oxidative stress
- Antioxidant effects; neuroprotection; may modulate mitochondrial function
- Investigational for neurodegenerative conditions; not relevant to circadian or sleep applications
- Supraphysiological doses (>3mg) activate MT3 sites, but clinical significance for sleep remains speculative. Most effects are likely MT1/MT2-mediated
- Peripheral Melatonin Receptors
- GI tract, pancreas, immune cells, cardiovascular tissue
- Same MT1/MT2 subtypes; modulate insulin secretion, immune function, vascular tone
- Regulates glucose metabolism, inflammatory cytokine release, blood pressure rhythms
- Type 2 diabetes management (melatonin reduces nocturnal insulin resistance); immune modulation in shift workers
- Peripheral receptor activation explains why melatonin affects metabolic and immune rhythms beyond sleep. Effects often overlooked in standard sleep supplement literature